Cargando…
Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series
BACKGROUND: The weight-gain caused by many psychotropic drugs is a major cause for poor compliance with such medications and could also increase cardio-vascular morbidity among psychiatric patients. Recent reports have shown that the anticonvulsant topiramate causes weight loss in various patient gr...
Autores principales: | Kirov, George, Tredget, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087494/ https://www.ncbi.nlm.nih.gov/pubmed/15817130 http://dx.doi.org/10.1186/1471-244X-5-19 |
Ejemplares similares
-
Successful Use of Add - On Topiramate for Antipsychotic - Induced Weight Gain
por: Shivakumar, Venkataram, et al.
Publicado: (2012) -
Topiramate Add-on Lithium Carbonate for Treatment of Acute Mania
por: Mirsepassi, Zahra, et al.
Publicado: (2013) -
Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder
por: Berlant, Jeffrey L
Publicado: (2004) -
Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
por: Huang, Yinglin, et al.
Publicado: (2017) -
Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2018)